Ventura Cannabis (VCAN) Posts Audited Financial Statements; Highlights Cannabis Market Position in California and Oregon
30 June 2020 - 11:00PM
Ventura Cannabis and Wellness Corp. (CSE:VCAN) (“Ventura Cannabis”,
“VCAN”, or the “Company”) today posted its audited financial
statements and accompanying management discussion & analysis
for the year ending February 29, 2020. The financial statements and
accompanying documentation are available at www.sedar.com.
In addition to the release of financial statements, the Company
provided highlights of its cannabis assets:
In California:
Ventura holds a Type 6 manufacturing cannabis license for adult
and medical use located in the San Francisco Bay Area with an open
plan 700 square foot facility.
It holds a state-wide Type 11 distribution cannabis license for
adult and medical use and is the majority owner of a delivery only
adult-use dispensary license in Sacramento.
It has developed an initial vape brand and has a limited
inventory order in place. All of these California assets have
tremendous revenue potential when fully operational.
In Oregon, Ventura has a strong revenue generating, luxury
retail dispensary for adult and medical use located in a high
traffic section of Portland, Oregon.
It also has an opportunity to acquire a processing and wholesale
license that is in final stages of transfer.
“I am proud of the Ventura team for building out a suite of
cannabis assets in a short period of time in a challenging market,”
said Chris Heath, CEO of Ventura Cannabis. “Despite the industry
challenges facing us over the past year, our team has developed
solid revenue-generating cannabis assets in California and Oregon,
as well as a strong balance sheet with no debt. We plan to use our
remaining cash to sustain these assets and look for strategic
opportunities until the capital market interest returns for our
type of assets.”
As of February 29, 2020, the Company’s fiscal year end, Ventura
had generated substantial cannabis revenues despite only beginning
to invest in cannabis revenues after the shareholder vote in April
2019. Cash as of February 29, 2020 was $3.9M with accounts payables
being reduced in the fourth quarter by over $1.7M, leaving a
payable balance at year end of $2.5M.
“As we approach the finalization of the disposition of the rehab
business, we have seen a significant reduction in our accounts
payable, and a resulting drop in cash,” continued Mr. Heath. “The
COVID-19 pandemic has unfortunately slowed down the divestment
process and we expect more payables to be resolved in the current
quarter, but thankfully we are close to completion and expect to be
able to proceed solely as a cannabis company soon.”
Moving forward as a dedicated cannabis company we do not
anticipate additional material impacts from the COVID-19 global
pandemic.
For more information contact:
Ventura Cannabis and Wellness Corp. Chris Heath CEO (424)
372-1123 investor@venturacanna.com www.venturacanna.com
Certain statements contained in this presentation constitute
“forward-looking information” as such term is defined in applicable
Canadian securities legislation. The words “may”, “would”, “could”,
“should”, “potential”, “will”, “seek”, “intend”, “plan”,
“anticipate”, “believe”, “estimate”, “expect”, “confident” and
similar expressions as they relate to the Company. Such statements
reflect the Company’s current views and intentions with respect to
future events, and current information available to the Company,
and are subject to certain risks, uncertainties, and assumptions.
The forward-looking information included are made as of June 30,
2020, and the Company undertakes no obligation to publicly update
or revise any forward-looking information, other than as required
by applicable law. VCAN holds or is acquiring marijuana assets in
the United States. Previously disclosed acquisitions are still
subject to closing. Marijuana is legal in each state VCAN is
looking to operate, however marijuana remains illegal under US
federal law, and the approach to enforcement of US federal law
against marijuana is subject to change. Shareholders and investors
need to be aware that adverse enforcement actions could affect
their investments and that VCAN’s ability to access private and
public capital could be affected and or could not be available to
support continuing operations.
Ventura Cannabis and Wel... (CSE:VCAN)
Historical Stock Chart
From Nov 2024 to Dec 2024
Ventura Cannabis and Wel... (CSE:VCAN)
Historical Stock Chart
From Dec 2023 to Dec 2024